ABT 199 is a potent and selective BCL-2 inhibitor that achieves potent antitumour activity while sparing platelets. Its practical application is to treat chronic lymphocytic leukaemic cells and estrogen receptor-positive breast cancer. Molecular Formula: C45H50ClN7O7S Solubility: Chloroform (Slightly, Heated), DMSO (Slightly, Heated) Molecular Weight: 868.44 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molekulargewicht:
868.44
Formulierung:
Supplied as a Yellow Solid
CAS Nummer:
[1257044-40-8]
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten